Medicine">
TCC Cannabis - Diego Rafhael Soares Carvalho Feitosa
TCC Cannabis - Diego Rafhael Soares Carvalho Feitosa
TCC Cannabis - Diego Rafhael Soares Carvalho Feitosa
SUMÁRIO
1 – INTRODUÇÃO.......................................................................................................2
2 - RELATO DE CASO.................................................................................................4
3 - CONSIDERAÇÕES FINAIS....................................................................................6
4 – REFERÊNCIAS......................................................................................................7
2
1 INTRODUÇÃO
2 RELATO DE CASO
3 CONSIDERAÇÕES FINAIS
4 REFERÊNCIAS
1. French JA, Pedley TA. Clinical practice. Initial management of epilepsy. N Engl J
Med. 2008 Jul 10;359(2):166-76.
7. dos Santos RG, Hallak JE, Leite JP, Zuardi AW, Crippa JA. Phytocannabinoids
and epilepsy. J Clin Pharm Ther. 2015 Apr; 40(2):135-43.
9. Brodie, M. J. Antiepileptic drug therapy the story so far. Seizure 2010, 19, 650.
10. Elmes, S. J.; Jhaveri, M. D.; Smart, D.;Kendall, D. A.; Chapman, V. Cannabinoid
CB2 receptor activation inhibits mechanically evoked responses of wide dynamic
range dorsal horn neurons in naïve rats and in rat models of inflammatory and
neuropathic pain. European Journal of Neuroscience 2004, 20, 2311.
11. Niesink, R. J.; Van Laar, M. W. Does Cannabidiol Protect Against Adverse
Psychological Effects of THC? Frontiers in Psychiatry 2013, 4, 1.